1-(4-((6-(Isobutylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea

ID: ALA4865829

PubChem CID: 164625575

Max Phase: Preclinical

Molecular Formula: C22H22F3N5O2

Molecular Weight: 445.45

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)CNc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1

Standard InChI:  InChI=1S/C22H22F3N5O2/c1-14(2)12-26-19-11-20(28-13-27-19)32-18-8-6-16(7-9-18)29-21(31)30-17-5-3-4-15(10-17)22(23,24)25/h3-11,13-14H,12H2,1-2H3,(H,26,27,28)(H2,29,30,31)

Standard InChI Key:  VHHKKIFOCYZSOY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 34  0  0  0  0  0  0  0  0999 V2000
   11.4200   -7.4950    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.0156   -8.2049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8326   -8.2003    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    1.8187   -7.0204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8175   -7.8399    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2324   -7.0168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5238   -6.6115    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9386   -6.6055    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6478   -7.0114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6476   -7.8263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3560   -8.2322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0631   -7.8208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0574   -6.9994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3484   -6.5973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7729   -8.2258    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4785   -7.8136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1883   -8.2186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4744   -6.9964    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8939   -7.8064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6018   -8.2132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3070   -7.8017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3032   -6.9836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5885   -6.5788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8863   -6.9927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0203   -9.0242    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.2398   -7.8392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5248   -8.2467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5232   -9.0639    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8147   -9.4711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8131  -10.2883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1045  -10.6955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5200  -10.6983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  2  0
  5 27  1  0
 26  6  1  0
  6  7  2  0
  7  4  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21  2  1  0
  2 25  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4865829

    ---

Associated Targets(Human)

TNNI3K Tchem Serine/threonine-protein kinase TNNI3K (615 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.45Molecular Weight (Monoisotopic): 445.1726AlogP: 6.00#Rotatable Bonds: 7
Polar Surface Area: 88.17Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.53CX Basic pKa: 4.75CX LogP: 5.48CX LogD: 5.48
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.42Np Likeness Score: -1.59

References

1. Patterson JR, Graves AP, Stoy P, Cheung M, Desai TA, Fries H, Gatto GJ, Holt DA, Shewchuk L, Totoritis R, Wang L, Kallander LS..  (2021)  Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf.,  64  (21.0): [PMID:34699203] [10.1021/acs.jmedchem.1c00700]

Source